Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

FDA审查周期延长、欧盟MDR新规等一系列变动都要求企业在合规上投入更多资源，尤其是在临床试验、数据提交和产品认证的 ...

Akeso has won the FDA’s go-ahead for its PD-1 inhibitor penpulimab co-developed with Sino Biopharmaceutical’s Chia Tai-Tianqing Pharmaceutical. To be marked as Anniko, penpulimab is approved ...

HIALEAH, Fla. – A 49-year-old man from Hialeah was arrested Tuesday after he posed as an immigration attorney and scammed a woman from Alabama. Recommended Videos According to Hialeah police, in ...

At the first pre-specified interim analysis of the 532-patient Chinese study, ivonescimab plus chemotherapy “decisively beat” BeiGene’s PD-1 inhibitor Tevimbra plus chemotherapy, Akeso said.

2025年4月23日早间，康方生物宣布双抗药物依沃西又一次在头对头试验中战胜了PD-1。该试验为一线治疗晚期鳞状非小细胞肺癌的注册性III期头对头 ...

HARMONi-6 is evaluating ivonescimab in combination with platinum-based chemotherapy compared with tislelizumab, a PD-1 inhibitor, in combination with platinum-based chemotherapy in patients with ...

百奥泰生物制药股份有限公司（证券代码：688177）最近收到国家药品监督管理局核准签发的关于公司在研产品注射用BAT7111的《药物临床试验批准通知 ...

MIDLAND, Texas — A juvenile victim was flown to Covenant Hospital in Lubbock for treatment following a shooting in Washington Park in Midland. The City of Midland's Spokesperson said, the ...

Common AEs included decreased leukocyte and neutrophil counts, anemia, diarrhea, nausea, lymphopenia ... for both indications. 1 1. Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant ...

Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education and School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China ...